Global Smart Medical Devices Market to Reach USD 82.0 Billion by 2033, Impelled by Continual Developments in Healthcare Sector

December 20, 2024 | Healthcare

According to the latest report by IMARC Group, titled "Smart Medical Devices Market Report by Product Type (Diagnostic and Monitoring, Therapeutic Devices), Distribution Channel (Pharmacies, Online, and Others), Application (Oncology, Diabetes, Auto-Immune Disorders, Infectious Diseases, and Others), End User (Hospitals and Clinics, Home-Care Setting, and Others), and Region 2025-2033," the global smart medical devices market reached a value of USD 45.9 Billion in 2024. Smart medical devices refer to equipment that are widely used by healthcare professionals for collecting data and delivering therapy to patients. They are mainly equipped with connectivity capabilities, such as wireless fidelity (Wi-Fi), near-field communication (NFC) and actuators, that trigger pre-set programmed functions. As a result, they are extensively adopted across clinics and hospitals to mitigate healthcare-related problems in order to deliver quality medical facilities to the masses. Besides this, they also assist in enhancing safety, reducing workload, increasing patient engagement, saving time, reducing errors and improving communication.

Global Smart Medical Devices Market Trends:

The global market is primarily driven by significant growth in the healthcare sector. Along with this, the growing investments by public and private agencies for upgrading the overall healthcare infrastructure are creating a positive market outlook. Moreover, the increasing prevalence of chronic diseases among the masses and the rising geriatric population, which is more prone to developing medical ailments, are providing a boost to the demand for smart medical devices. Additionally, continual technological advancements, such as the integration of the internet of things (IoT), sensors and artificial intelligence (AI) with medical devices, are significantly supporting the market on the global level. Furthermore, the rapid outbreak of coronavirus disease (COVID-19) has also propelled the market growth. The market is further driven by numerous initiatives undertaken by the governments of several countries to spread awareness regarding disease prevention. Other factors, including rapid digitization, the growing preference for home treatments, the rising health consciousness among the masses and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 82.0 Billion by 2033, exhibiting a CAGR of 6.33% during 2025-2033.

Market Summary:

  • On the basis of product type, the market has been segmented into diagnostic and monitoring (blood glucose monitors, heart rate monitors, pulse oximeters, blood pressure monitors, breath analyzer and other diagnostic monitoring products) and therapeutic devices (portable oxygen concentrators and ventilators, insulin pumps, hearing aid and other therapeutic devices).
  • Based on the distribution channel, the market has been segregated into pharmacies, online and others.
  • On the basis of the application, the market has been categorized into oncology, diabetes, auto-immune disorders, infectious diseases and others.
  • Based on the end-user, the market has been classified into hospitals and clinics, home-care setting and others.
  • On the basis of the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Abbott Laboratories, Activinsights Ltd, Apple Inc., Debiotech SA, Enable Injections, Fitbit LLC (Google LLC), Koninklijke Philips N.V., Medtronic PLC, NeuroMetrix Inc., Omron Healthcare Co Ltd (Omron Corporation), Sonova Holding AG, Sotera Wireless Inc. and VitalConnect.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product Type, Distribution Channel, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Activinsights Ltd, Apple Inc., Debiotech SA, Enable Injections, Fitbit LLC (Google LLC), Koninklijke Philips N.V., Medtronic PLC, NeuroMetrix Inc., Omron Healthcare Co Ltd (Omron Corporation), Sonova Holding AG, Sotera Wireless Inc. and VitalConnect.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Smart Medical Devices Market to Reach USD 82.0 Billion by 2033, Impelled by Continual Developments in Healthcare Sector
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials